AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04174573 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: GT-tDCS
Description: 1. Group therapy~   1. Forward direction activity: Balance activity in forward direction on wooden balance board (5 reps X 3 sets X 2 days in a week, for 6 weeks)~  2. Backward direction activity: Balance activity in backward direction on wooden balance board (5 reps X 3 sets X 2 days in a week, for 6 weeks)~  3. Sideways direction activity: Balance activity in sideways direction on wooden balance board (5 reps X 3 sets X 2 days in a week, for 6 weeks)~2. tDCS Left anodal and right cathodal tDCS : Anode- F3, Cathode- Right Supra orbital area, Intensity- 2mA, Duration- 30 minutes, once in a week for 6 weeks
Study NCT05598034 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Left DLPFC tDCS
Description: This intervention involves placing non-invasive scalp-electrodes over the left DLPFC brain region to deliver a mild, tolerable electric current.
Study NCT05598034 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Right DLPFC tDCS
Description: This intervention involves placing non-invasive scalp-electrodes over the right DLPFC brain region to deliver a mild, tolerable electric current.
Study NCT05598034 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive task
Description: Participants will be asked to perform a 2-back working memory mental task alongside administered tDCS
Study NCT05709782 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Spine Radiosurgery
Description: scan
Study NCT05709782 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance imaging
Description: scan
Study NCT05709782 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: MR-LINAC
Description: scan
Study NCT04954859 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bepirovirsen
Description: No study drug will be administered in this study. Eligible participants who received prior treatment with bepirovirsen in the parent studies will be included.
Study NCT04954859 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: No study drug will be administered in this study. Eligible participants who received prior treatment with placebo in the parent studies (209668, 202009, and 219288) will be included to maintain the blind in the still ongoing parent studies.
Study NCT05135273 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pfs230D1-EPA/Matrix-M Vaccine
Description: Each single-use vial of Pfs230D1M-EPA contains 160 µg/mL of conjugated Pfs230D1M and 124 µg/mL or 143 µg/mL of conjugated EPA in 4 mM phosphate-buffered saline (PBS), in a volume of 0.5 mL. Each vial of Matrix-M1 contains saponin content of 0.375 mg/mL in PBS, at a pH of 7.2, in a final volume of 0.75 mL. Components will be combined in volumes defined in the protocol at point of use.
Study NCT06634771 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 10 Hz transcranial alternating current stimulation (tACS)
Description: 10 Hz bi-frontal tACS: Alternating current stimulation is delivered by an XCSITE 100 device (Pulvinar Neuro, Chapel Hill, NC), through three conductive carbon-rubber electrodes. Electrodes are placed over the apex of the head (Cz) and the prefrontal cortex bilaterally (F3 and F4). Stimulation is delivered during the second half of the HABIT Test session. Stimulation parameters: 2mA peak-to-peak 10Hz sine-wave flanked by 10 second linear envelope ramps in and out for a total duration of 30 min and 20 seconds.
Study NCT06634771 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: sham transcranial alternating current stimulation (tACS)
Description: Sham tACS: The procedure for sham stimulation will be identical, but it will last for 2 minutes instead of 30 minutes.
Study NCT05135273 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Verorab Rabies Vaccine
Description: Verorab Rabies Vaccine is a purified inactivated rabies vaccine (Wistar rabies PM/WI 38 1503-3M strain) prepared on Vero cells. It is supplied as a powder and solvent for suspension for injection in a prefilled syringe. Before reconstitution, the powder is a white and homogeneous pellet. The solvent is a limpid solution.
Study NCT06631391 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: umbilical cord blood NK cells
Description: This is a phase I prospective clinical trial, including phase Ia and phase Ib. Phase Ia include 3 dose levels, utilizing a 3+3 design principle, and each dose level will enroll at least 3 subjects. The recommended dose for phase Ia was used in phase Ib. Each patient receives two courses of umbilical cord blood NK cell therapy (a total of 8 infusions of umbilical cord blood NK cells).
Study NCT06515652 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: rosuvastatin, METFORMIN, Sitagliptin, Telmisartan, Cinnamon. garlic, Ginger, Methi dana, Arjun
Description: Comparing allopathic and herbal group of drugs for metabolic syndrome
Study NCT05450978 — intervention group
Intervention type: DRUG
Intervention: Lamotrigine
Description: Anti-seizure concentrations
Study NCT05450978 — intervention group
Intervention type: DRUG
Intervention: Levetiracetam
Description: Anti-seizure concentrations
Study NCT05468918 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Phonak Audeo previous generation hearing aids
Description: Receiver-in-canal (RIC) hearing aids with universal earpieces
Study NCT05468918 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Phonak Audeo Lumity hearing aids
Description: Receiver-in-canal (RIC) hearing aids with universal earpieces
Study NCT06006286 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atezolizumab
Description: Given by IV (vein)
Study NCT06006286 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: Given by IV (vein)
Study NCT06006286 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ADI-PEG 20
Description: Given by Injection (inj)
Study NCT06035887 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Hand-Held Full-Field Skin-Electrode Electroretinography (Device to be evaluated)
Description: RETEval Complete hand-held electroretinogram
Study NCT06035887 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Trolley-Mounted Multifocal Skin-Electrode Electroretinography (Device to be evaluated)
Description: UTAS multifocal electroretinogram
Study NCT06035887 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Spectral-Domain Optical Coherence Tomography (Standard of Care test)
Description: Heidelberg Engineering Spectralis Spectral-Domain Optical Coherence Tomography (macular structural scan)
Study NCT06035887 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Macular Autofluorescence (Standard of Care test)
Description: Heidelberg Engineering Spectralis Autofluorescence imaging (macular structural image)
Study NCT04753567 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: nCap pain relief patch
Description: Each participant will be randomly assigned to sham or actual patch. Patches will be worn for 3 weeks. Pain and quality of life will be assessed and compared between groups
Study NCT04753567 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Sham Patch
Description: Sham patch will be worn for 3 weeks exactly like actual pain patch
Study NCT04743232 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Decision tool for clinicians
Description: Clinical decision aid, using a structured approach to advanced care directives and a comprehensive view of available risk scores.
Study NCT06024226 — intervention group
Intervention type: PROCEDURE
Intervention: Tumor samples
Description: Tumor samples will be collected by the pathologist at the reception of the tumor removed during surgery
Study NCT05507528 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: reborn treatment
Description: Fat reduction treatments with the ReBorn LED System visit - include the treatment procedure
Study NCT05381597 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Combination cream of 5-fluorouracil and calcipotriene
Description: Apply the cream to the size of the lesion extending to the 0.5 cm area of skin surrounding the lesion.twice a day for 7 days and the treatment can be extended to 14 days based on evaluation at 7 days.
Study NCT05381597 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 5-fluorouracil cream
Description: Apply the cream to the size of their lesion extending to the 0.5 cm area of skin surrounding the lesion twice daily for 28 days.
Study NCT05954819 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Planned patient education
Description: Patients in the experimental group will be given about 30 minutes of patient education. After the training, a Patient Education Booklet containing Myocardial Infarction and Diabetes Education will be presented to the patients. Control group patients will not be given any training other than the hospital routine.
Study NCT05609747 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Nonsurgical root canal therapy
Description: After administration of LA and rubber dam isolation, acess cavity will be prepared using carbide burs in high speed hand piece with copious irrigation. Working length will be determined using root ZX apex locator and will be verified radiographically. Canal preparation will be done with protaper rotary instruments in which Sx to S2 will be used to shape the canals and F1 and F2 will be used to finish until the apex. 5ml of 5.25% NaOCl will be used as irrigant after each instrument. After instrumentation , the canals will be irrigated with 5.0 ml of 17% EDTA for 1minute followed by irrigation with 5.0 ml of 5.25% NaOCl. Canals will be dried with absorbent paper points, filled with calcium hydroxide paste and access cavity will be restored with IRM. Patients will be recalled after 1 week.At the next appointment, after paste removal, copious irrigation with 5.25% NaOCl will be done and canals will be dried with paper points. Canals will be obturated with Gutta-Percha and ZOE based sealer.
Study NCT05146232 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: induction of anesthesia
Description: induction of anesthesia during gastric sleeve surgery
Study NCT05146232 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: maintainance of anesthesia
Description: maintainance of anesthesia during gastric sleeve surgery either opioid free or opioid based
Study NCT06184594 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: eNav
Description: The eNav toolkit is a digital navigation toolkit that includes a website and text messaging support. The website includes information, motivational support, decisional support and cues to action (e.g., ability to request a CRC screening test). The eNav tool also includes text-messaging based navigation (e.g., reminders, instructions to complete the screening test).
Study NCT06184594 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Standard of Care
Description: Standard of care procedures for selecting their CRC screening test.
Study NCT05518032 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biopsy
Description: Undergo biopsy
Study NCT05518032 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Given IV
Study NCT05518032 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Therapeutic Autologous Dendritic Cells
Description: Given intratumorally
Study NCT05633082 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Lens 1 (omafilcon B)
Description: Toric daily wear contact lens for 15 minutes
Study NCT05633082 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Lens 2 (fanfilcon A)
Description: Toric daily wear contact lens for 15 minutes
Study NCT06294587 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: FGG Before GBR
Description: Free Gingival Graft before the guided bone regeneration,
Study NCT06294587 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: FGG after GBR
Description: Free Gingival Graft after the guided bone regeneration,
Study NCT06456671 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: All nicotine/ tobacco products at market price
Description: Nicotine/tobacco products available in the Experimental Tobacco Marketplace at market price. Note that all participants will complete all the specified conditions.
Study NCT06456671 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nicotine vaping products at 1/2 market price
Description: Availability of nicotine vaping products in the Experimental Tobacco Marketplace at 1/2 market price. Other nicotine/tobacco products at market price. Note that all participants will complete all the specified conditions.
Study NCT06456671 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Heated tobacco products at 1/2 market price.
Description: Availability of heated tobacco products in the Experimental Tobacco Marketplace at 1/2 market price. Other nicotine/tobacco products at market price. Note that all participants will complete all the specified conditions.
Study NCT06456671 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nicotine pouch products at 1/2 market price.
Description: Availability of heated tobacco products in the Experimental Tobacco Marketplace at 1/2 market price. Other nicotine/tobacco products at market price. Note that all participants will complete all the specified conditions.
Study NCT06564571 — intervention group
Intervention type: DEVICE
Intervention: Patients undergoing endoscopic ultrasound procedures
Description: Patients will undergo endoscopic ultrasound procedures as planned. Abnormalities in the pancreas identified by the endoscopist during the endoscopic ultrasound examination will be correlated against those detected by the AI platform.
Study NCT05029388 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aerobic Exercise
Description: The participants will complete three training sessions per week over 10 weeks. The aerobic training program will last for one hour. The session will include a 10-minute warm-up period, followed by a 45-minute aerobic workout, wherein the participants can choose to use either a treadmill, a cycle ergometer, or a rowing ergometer. After the workout, a five-minute period of stretching will be provided for cooling down. The intensity during the workout will be set at 40%-55% of the individual's maximum heart rate.
Study NCT05029388 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High Intensity Interval Training
Description: The intervention will be conducted over a period of 10 weeks, while the participants will complete three training sessions per week. The HIIT training program will last for 30 minutes. The session will include a 10-minute warm-up period, followed by a 15-minute HIIT workout, and a 5-minute period of stretching to cool down. The exercises will include repeated, high-intensity intermittent bursts of vigorous activity at maximal effort. The HIIT will mainly include bodyweight exercises (e.g., push-ups, squats, lunges) that disregards equipment usage. The intensity during the workout will be set to 85%-95% of the individual's maximum heart rate. A half-day training workshop will be provided to the personal trainer to ensure that he/she knows the exercises and can demonstrate them to the participants.
Study NCT06519526 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR-0302
Description: SHR-0302 will be administered orally as tablets.
Study NCT06519526 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR-2554
Description: SHR-2554 will be administered orally as tablets.
Study NCT04956016 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: classic rTMS using the 8-shaped coil
Description: 20 rTMS sessions are planned (5 sessions per week)
Study NCT04956016 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: deep rTMS using the H1-shaped coil
Description: 20 rTMS sessions are planned (5 sessions per week)
Study NCT04794504 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Botox 100 UNT Injection
Description: Botox will be injected intramuscularly into the masseter and temporalis muscles bilaterally to investigate if it can supplement postoperative analgesia in orthognathic surgery patients
Study NCT04794504 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: 0.9% Saline Injection
Description: As a placebo control to the 100 UNT Botox injection, 0.9% saline will be injected intramuscularly into the masseter and temporalis muscles bilaterally
Study NCT06003504 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: First aid training with blended learning approach
Description: The content of the first aid blended learning training is standardised and based on the 2021 edition of the Basic First Aid in Africa manual from the Belgian Red Cross, covering first aid general principles and instructions for:~* emergencies (i.e. choking, unconsciousness with and without normal breathing, chest discomfort and stroke, poisoning, and severe external bleeding);~* injuries (i.e. skin wounds, burns, and injuries to muscles, joints, limbs, head, neck, and back);~* illnesses (i.e. fainting, fever, fits, and diarrhoea).~The training consists of 2 consecutive parts:~1. First aid theory is learned independently in a mobile application followed by an online test to ob-tain an admission ticket for the subsequent in-class training;~2. First aid skills are practiced during a 1-day in-class training facilitated by a certified first aid instructor of the Rwanda Red Cross.~Participants get at least 10 days to learn in the mobile application and obtain the admission ticket.
Study NCT06003504 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: First aid training with face-to-face approach
Description: The content of the first aid face-to-face training is standardised and based on the 2021 edition of the Basic First Aid in Africa manual from the Belgian Red Cross, covering first aid general principles and instructions for:~* emergencies (i.e. choking, unconsciousness with and without normal breathing, chest discomfort and stroke, poisoning, and severe external bleeding);~* injuries (i.e. skin wounds, burns, and injuries to muscles, joints, limbs, head, neck, and back);~* illnesses (i.e. fainting, fever, fits, and diarrhoea).~The training consists of a 3-days in-class training with lectures and practical exercises on first aid the-ory and skills, facilitated by a certified first aid instructor of the Rwanda Red Cross.
Study NCT05918185 — intervention group
Intervention type: PROCEDURE
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study NCT05918185 — intervention group
Intervention type: OTHER
Intervention: Comprehensive Geriatric Assessment
Description: Undergo cGA
Study NCT05918185 — intervention group
Intervention type: OTHER
Intervention: Electronic Health Record Review
Description: Medical records are reviewed
Study NCT05918185 — intervention group
Intervention type: OTHER
Intervention: Survey Administration
Description: Complete surveys
Study NCT05022719 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PillCam Colon2 procedure with MB-MMX
Description: Subjects will undergo a bowel preparation (single dose, 4L PEG), including 200 mg Methylthioninium chloride, corresponding to eight 25 mg MB-MMX tablets and 1 tab of Resolor (Prucalopride 1mg). An experienced Gastroenterologist will read the CCE procedure and complete a subjective questionnaire, to evaluate mucosal enhancement during a CCE procedure, when using MB-MMX as a contrast-enhancement technique.
Study NCT04907084 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Serine
Description: Powdered serine supplement (Dosed out individually per participant. Participant to mix with water and ingest orally)
Study NCT04907084 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fenofibrate
Description: Fenofibrate 160mg pill, taken orally
Study NCT05937243 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Base self-help CBT program
Description: The self-help app will deliver 12 modules that will be based on Chris Fairburn's Overcoming Binge Eating self-help book, the most widely used self-help resource for binge eating over 12 weeks. Treatment modules will aim to 1) provide psychoeducation on maintenance factors for binge eating, 2) teach CBT skills designed to interrupt these maintenance factors, and 3) coach participant to set personalized goals each week. Modules will be completed in succession over the course of 12-weeks and a new module will be made open each week. In addition, participants will track their eating and eating disorder behaviors using the self-help app.
Study NCT05937243 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Base self-help CBT program
Description: The self-help app will deliver 12 modules that will be based on Chris Fairburn's Overcoming Binge Eating self-help book, the most widely used self-help resource for binge eating over 12 weeks. Treatment modules will aim to 1) provide psychoeducation on maintenance factors for binge eating, 2) teach CBT skills designed to interrupt these maintenance factors, and 3) coach participant to set personalized goals each week. Modules will be completed in succession over the course of 12-weeks and a new module will be made open each week. In addition, participants will track their eating and eating disorder behaviors using the self-help app.
Study NCT05937243 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Just-in-time, adaptive intervention (JITAIs) system
Description: When JITAIs are turned ON, the base self-help app will be used to deliver targeted, personalized and automated interventions during algorithm-identified moments when participants could benefit from receiving an intervention for improving two key areas including 1) treatment adherence, and 2) skills utilization based on responses (or lack thereof) in self-help app. When JITAIs are turned OFF, participants will not receive interventions in real-time on the base self-help app.